Jonathan B. Zung

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Diantha Duvall, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan B. Zung:

Company Role Class Num Shares Value Price $ Report Date Ownership
CURIS INC CDO Employee stock option (right to buy) 40,700 $472,934 $11.62 21 May 2024 Direct
CURIS INC CDO Employee stock option (right to buy) 135,000 $422,550 $3.13 20 May 2025 Direct
Evelo Biosciences, Inc. Chief Development Officer Stock Option (Right to Buy) 115,000 19 Jul 2022 Direct

Insider Reports Filed by Jonathan B. Zung

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRIS CURIS INC 20 May 2025 1 +$422,550 4 CDO 22 May 2025, 16:12
CRIS CURIS INC 28 Jan 2025 1 +$46,950 4 CDO 30 Jan 2025, 16:08
CRIS CURIS INC 21 May 2024 1 +$472,934 4 CDO 23 May 2024, 16:10
CRIS CURIS INC 01 May 2023 1 +$415,000 4 CDO 03 May 2023, 16:12
CRIS CURIS INC 01 May 2023 0 $0 3 CDO 03 May 2023, 16:07
/report/000169466522000134-zung-jonathan-b-2022-07-19 Evelo Biosciences, Inc. 19 Jul 2022 1 $0 4 Chief Development Officer 14 Oct 2022, 16:32
/report/000169466522000019-zung-jonathan-b-2022-01-19 Evelo Biosciences, Inc. 19 Jan 2022 1 $0 4 Chief Development Officer 21 Jan 2022, 15:56